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Toll-like receptors (TLRs) play a pivotal role in pathogen
recognition and subsequent cytokine synthesis by immune
cells. Uremic patients have a high infectious morbidity, but it
remains unclear if this arises from the defective innate
immune responses related to TLRs. We studied TLR4
expression in monocytes and their intracellular cytokine
synthesis in response to lipopolysaccharide (LPS) stimulation
in 35 predialysis patients with chronic kidney disease (CKD)
with or without predisposition to bacterial infections and 16
age-matched controls. Expression of TLR4 in unstimulated
peripheral monocytes was determined by staining with
anti-TLR4 antibody and analysis with flow cytometry.
Monocytes were then stimulated by LPS, labeled with
anti-CD14 antibody, and subjected to intracellular cytokine
staining and flow cytometry. Tumor necrosis factor (TNF)-a,
interleukin (IL)-1b, IL-6, and IL-8 synthesis was examined in
CD14þ monocytes. TLR4 expression was constitutively
diminished in CKD patients with reduced expression being
more severe in those CKD patients who were predisposed to
infections. Monocytes from these infection prone CKD
patients exhibited significantly reduced synthesis of TNF-a,
IL-1b, IL-6, and IL-8 in response to LPS challenge compared
with those from control subjects. The intensity of synthesis of
each cytokine significantly correlated with TLR4 expression
levels in monocytes (Po0.01). The capacity of monocytes to
synthesize proinflammatory cytokines was significantly
reduced in infection prone CKD patients, and this may
possibly be due to the reduced monocyte expression of TLR4.
Abnormal TLR4 expression by monocytes may play a role in
the susceptibility of such patients to bacterial infections.
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Patients with chronic kidney disease (CKD) as well as dialysis
patients have an increased incidence of infections,1 and this
suggests that innate defense systems are impaired in uremic
patients. Microbial recognition and subsequent release of
proinflammatory cytokines are critical features of the innate
host defense system against microorganisms. Members of the
Toll-like receptor (TLR) family are responsible for the
recognition of pathogen-associated molecular patterns
expressed by a wide spectrum of infectious agents. TLRs
activate the nuclear factor-kB pathway through several
adaptor molecules, and therefore regulate cytokine expres-
sion. Activation of the nuclear factor-kB pathway links the
innate and adaptive immune response via the production of
inflammatory cytokines and the induction of costimulatory
molecules.2 Although at least 10 TLRs have been identified in
humans, TLR4 is a key player as it recognizes lipopoly-
saccharide (LPS) of Gram-negative bacteria bound to CD14.
Ligation of TLR4 induces production of proinflammatory
cytokines such as tumor necrosis factor (TNF)-a, interleukin
(IL)-1, IL-6, and IL-8. Consequently, the expression levels of
TLR4 may be involved in regulating the propensity of
immune cells to cytokine synthesis following LPS stimulation
and initiating a response that effectively eliminates Gram-
negative bacterial infections.3,4 However, the level of TLR4
expression and its involvement in cytokine response have not
been studied in CKD patients.
It is becoming increasingly clear that the appropriate
induction of cytokines by immune cells is necessary for the
full development of the innate host defense. Cytokines exert
their major physiologic and pathophysiologic effects as
autocrine or paracrine factors. Therefore, altered local
processing and release of cytokines are very relevant in the
pathogenesis of innate immune dysfunction. The study of
circulating cytokine levels has limited value and gives little
information as a result of their short half-lives and important
local effects.5 In contrast, measuring the capacity of
peripheral blood cells to synthesize cytokines in response to
pathogenic stimuli may provide a more precise and relevant
picture in clinical practice.5–7
To elucidate the effects of uremia upon the capacity of
innate host defense toward an infectious challenge, we
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investigated constitutive expression of TLR4 in peripheral
monocytes and the intracellular synthesis of proinflamma-
tory cytokines in response to LPS stimulation. It is well
described that dialysis may significantly influence cytokine
production whereas the predisposition toward infections
varies among individuals even within the uremic population.
Thus, in this study, we focused on predialysis CKD patients
who had been susceptible to bacterial infectious diseases.
RESULTS
Laboratory data of the subjects
The laboratory data of the subjects are shown in Table 1.
There were no significant differences in all laboratory
variables between the CKD patients with prior bacterial
infections and those without antecedent infections. The CKD
and control groups were comparable with respect to total
white blood cell, monocyte, and lymphocyte counts. The
hematocrit was significantly lower in the CKD patients. The
serum TNF-a, IL-1b, IL-6, and IL-8 levels were not different
between the CKD and control groups. As expected,
significant differences were observed between the CKD and
control groups with regard to serum parameters that are
related to uremia (estimated glomerular filtration rate, urea
nitrogen, creatinine, and b2 microglobulin levels), but there
were no differences apparent with regard to nutritional
parameters (total protein, albumin, and lipids levels). The
erythrocyte sedimentation rate was significantly higher
possibly due to anemia in the CKD patients but C-reactive
protein levels were not different.
Baseline expression of TLR4 in unstimulated peripheral
monocytes
We investigated the constitutive expression of TLR4 in
monocytes from 35 CKD patients and healthy controls. TLR4
expression was downregulated in CKD patients compared
with controls. The frequency of TLR4 positive cells (% of
positive cells) and the level of expression (mean fluorescence
intensity (MFI)) were significantly higher in control subjects
(frequency: 5.5270.518% and MFI: 3.8371.68) than in
CKD patients. This difference was more obvious in the 20
CKD patients with prior recurrent bacteria infections
(frequency: 1.3571.68% and MFI: 1.0370.0603) than in
the 15 CKD patients without prior infections (frequency:
3.6171.41% and MFI: 2.6271.00). The data are shown in
Figure 1.
Intracellular cytokine induction by monocytes in response
to LPS
This examination was performed in CKD patients (n¼ 20)
who had been predisposed to bacterial infections and age-
matched healthy controls (n¼ 16). There were no differences
in the intracellular monocyte cytokine levels between the two
groups in the absence of LPS stimulation as previously
described.8 However, significant differences were detected
between groups following LPS stimulation. Table 2 shows the
percentage of cells that were positive for TNF-a, IL-1b, IL-6,
and IL-8 (frequency), and the level of intracellular cytokine
synthesis expressed by MFI (intensity) in the CKD patients
and controls. The CKD patients exhibited a significantly
reduced frequency and intensity in the synthesis of all the
cytokines tested compared with the controls.
Table 1 | Laboratory data
CKD
(n=35)
Control
(n=16) P-values
WBC counts (/ml) 503871565 525871247 NS
Monocytes (/ml) 4277122 435788.0 NS
Lymphocytes (/ml) 13487665 15327888 NS
Hct (%) 30.977.1 44.574.4 Po0.05
Serum data
TP (g/dl) 6.871.4 7.071.3 NS
Alb (g/dl) 3.971.2 4.370.7 NS
UN (mg/dl) 68.179.3 11.873.2 Po0.01
Cr (mg/dl) 5.974.1 0.8470.3 Po0.01
b2MG (mg/dl) 12.773.56 0.9170.14 Po0.01
TC (mg/dl) 196723.2 236769.9 NS
TG (mg/dl) 1317113.6 104.5720.2 NS
ESR (mm/h) 17.178.78 8.5072.22 Po0.05
CRP (mg/dl) 0.270.1 0.170.2 NS
Estimated GFR (ml/min/1.73 m2) 15.472.67 84.874.65 Po0.01
Serum cytokine levels
TNF-a (pg/ml) 25.1720.2 23.0712.7 NS
IL-1b (pg/ml) 2.1172.74 1.9873.03 NS
IL-6 (pg/ml) 4.3172.00 3.8772.21 NS
IL-8 (pg/ml) 3087275 2977286 NS
Alb, albumin; b2MG, b2 microglobulin; CKD, chronic kidney disease; Cr, cratinine;
CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; GFR, glomerular
filtration rate; Hct, hematocrit; IL, interleukin; NS, nonsignificant; TC, total
cholesterol; TG, triglycerides; TNF, tumor necrosis factor; TP, total protein; UN, urea
nitrogen; WBC, white blood cell.
GFR is estimated by the Modification of Diet in Renal Disease equation.
Data are expressed as mean7s.d.
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Figure 1 | Surface expression of TLR4 in unstimulated monocytes
in CKD patients and age-matched control subjects (CONT). The
percentage of cells that are positive for anti-human TLR4 specific
mAb (frequency) is shown on the left side. Their MFI is on the right
side. The data are shown as mean (lower black column)7s.e. (upper
white column). P-values represent the comparison between CONT
(n¼ 16) and CKD (n¼ 35). Inf (þ ) CKD means CKD with prior
recurrent infections (n¼ 20). Inf () CKD means CKD without prior
recurrent infections (n¼ 15). *Po0.01 compared with CONT. #Po0.01
compared with Inf (–) CKD.
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Correlation of intracellular cytokine synthesis and TLR4
expression in monocytes
Intracellular synthesis of each cytokine was significantly
correlated with intensity of TLR4 expression in CKD patients
(n¼ 20) on bivariable analysis. In addition, the synthesis of
all cytokines except IL-8 was significantly correlated with the
frequency of TLR4 expressing cells (Table 3). The frequency
of cytokine producing cells had no significant correlation
with TLR4 expression. Cytokine synthesis had no significant
correlation with other clinical variables associated with renal
function such as serum creatinine, urea nitrogen, b2
microglobulin, and estimated glomerular filtration rate.
DISCUSSION
This study has focused upon the impairment of innate
immunity related to local cytokine responses in predialysis
CKD patients and the possible role of abnormal TLR4
expression. First, a significant reduction of TLR4 expression
was evident in CKD patients irrespective of predisposition to
bacterial infection, but it was more severe in CKD patients
with prior bacterial infections. Secondly, we found that LPS-
induced cytokine synthesis was impaired in the CKD patients
predisposed to bacterial infections. Finally, each cytokine
response exhibited a significant correlation with the expres-
sion level of TLR4 in monocytes. These findings suggest that
the significant reduction of TLR4 expression in monocytes in
CKD patients who are susceptible to infections may underlie
the impaired local cytokine synthesis by monocytes in
response to Gram-negative microorganisms.
To date, the factors that decrease TLR expression in vivo
are poorly understood. While Tamandl et al.9 have shown
that TNF-a reduces and IL-6 enhances TLR4 expression on
monocytes, our data did not show any difference in serum
levels of these cytokines between the CKD and control
subjects (Table 1). Also, these serum cytokine levels did not
exhibit any statistical correlation with TLR4 expression on
bivariable analysis (data not shown). To clarify whether
previous infections result in a residual immune deficit that
affects TLR4 expression, we compared TLR4 expression
between CKD patients with and without a predisposition to
bacterial infections. Our data indicate that the reduction in
TLR4 expression in CKD patients compared with healthy
controls occurs irrespective of the presence or absence of
prior bacterial infections (Figure 1). This suggests that the
decreased TLR4 expression is secondary to uremia per se and
is not the result of previous recurrent infections. However,
our study did not clarify the cause of the further reduced
TLR4 expression in CKD patients with a history of prior
recurrent infections. Genetic variations in individual TRL4
expression might be involved in this difference.
We studied the capacity of monocytes to synthesize
proinflammatory cytokines such as TNF-a, IL-1b, IL-6, and
IL-8 in response to LPS stimulation in the CKD patients who
were susceptible to infections. Our results showed that
cytokine synthesis was significantly reduced in these CKD
patients compared with the control subjects. In exerting their
major physiologic and pathophysiologic effects, cytokines act
as autocrine or paracrine entities. An inadequate or delayed
proinflammatory cytokine release in the local environment
may limit the immune response and increase the risk of
clinically significant infections.4,10,11 As a consequence of the
critically important local effects of cytokines and the short-
half-life of monokines, the study of blood levels is of limited
value.5 Indeed, several studies have demonstrated a correla-
tion between reduced proinflammatory monokine synthesis
in response to stimuli and a higher mortality in septic
patients even though plasma monokine levels are ele-
vated.12,13 This study did not address anti-inflammatory
cytokine profiles such as IL-10 synthesis and the ratio of
IL-10 to TNF-a, which also need to be considered in host
defense.14,15 We believe, however, that the reduction of
proinflammatory monokines is directly relevant to the
susceptibility to bacterial infections.10–13
To the best of our knowledge, there is little known about
the mechanisms regulating the production of cytokines by
peripheral blood monocytes in response to infectious stimuli
under chronically uremic conditions. We suggest that the
altered cytokine response to LPS is the result of abnormal
TLR4 expression since LPS binding to TLR4 triggers
monocyte cytokine production.2–4 Although the exact
mechanism is currently unclear, antibodies to TLR4 inhibit
LPS-induced cytokine production by human peripheral
blood mononuclear cells, human gingival fibroblasts, and
murine peritoneal macrophages.16,17 In fact, the clinical
relevance of TLR4 expression levels is suggested by the
Table 2 | Frequency and intensity of cytokine synthesis by
monocytes
Cytokines CKD (n=20) Control (n=16) P-values
TNF-a (%) 12.1714.7 25.6716.7 o0.01
TNF-a (MFI) 2.6270.602 3.4770.904 o0.01
IL-1b (%) 10.6720.6 29.6726.2 o0.05
IL-1b (MFI) 1.3370.249 1.7270.569 o0.05
IL-6 (%) 3.1272.97 9.5073.64 o0.01
IL-6 (MFI) 1.7570.363 2.3170.893 o0.01
IL-8 (%) 18.5721.9 30.7733.6 o0.01
IL-8 (MFI) 1.4270.337 1.8570.770 o0.05
CKD, chronic kidney disease; IL, interleukin; MFI, mean fluorescence intensity; TNF,
tumor necrosis factor.
P-values represent the comparisons between CKD and control.
Data are expressed as mean7s.d.
Table 3 | Correlation between intensity of cytokine synthesis
and TLR4 expression in CKD patients
Cytokine Correlation coefficient (n=20) P-value
TNF-a 0.825 (0.743) 0.0019 (0.0106)
IL-1b 0.779 (0.700) 0.0058 (0.0216)
IL-6 0.846 (0.835) 0.0010 (0.0014)
IL-8 0.745 (0.617) 0.0110 (0.0568)
CKD, chronic kidney disease; IL, interleukin; TLR4: Toll-like receptor 4.
Data in parenthesis indicate correlation coefficient and P-value for frequency of TLR4
expression.
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significant correlation with in vitro cytokine response at the
time of LPS stimulation in the CKD patients (Table 3).
In conclusion, CKD patients who are predisposed to
bacterial infections exhibit inadequate innate host defense
with respect to their ability to generate appropriate pro-
inflammatory cytokines in response to invading microorgan-
isms. This compromised cytokine response could be
associated with their severely decreased TLR4 expression.
MATERIALS AND METHODS
Patients
The study included 35 predialysis CKD patients (male/female, 20/15;
mean age, 62.376.31 years) and 16 age-matched healthy subjects
(male/female, 8/8; mean age, 61.376.11 years). Twenty CKD
patients had been hospitalized on at least two occasions for
treatment of infectious diseases such as pneumonia (n¼ 32),
urinary tract infections (n¼ 4), sepsis (n¼ 4), phlegmonous
cellulitis (n¼ 4), and cholecystitis (n¼ 2). The shortest time
between the last hospital discharge and entry into the study was 2
months and 11 days (the mean time was 3.871.8 months). Fifteen
CKD patients had no such medical history of infections. The mean
time from diagnosis of CKD to the study entry in 35 patients was
4.673.2 years. Eight out of 35 CKD patients had received
recombinant human erythropoietin administration but not iron
therapy. The dose of recombinant human erythropoietin was
200–400 U/kg per month. The chronic renal failure of the CKD
patients was due to the following diseases: nephrosclerosis (n¼ 23)
and chronic glomerulonephritis (n¼ 12). Any patient that had renal
failure due to collagen diseases, diabetes mellitus, and hepatitis C
was excluded from the study since the immune cells of such patients
are considered to be functionally abnormal. None of the subjects
took any drugs that can influence the immune system. The study
was approved by the institutional review board of the hospital, and
was conducted in accordance with the Declaration of Helsinki
Principles. Informed consent was obtained from all subjects.
Reagents and antibodies
Brefeldin-A and LPS were purchased from Sigma Chemicals (Tokyo,
Japan). The following reagents were purchased from Becton
Dickinson (CA, USA): fluorescence-activated cell sorter Lysing
Solutions, Permeabilizing Solutions, fluorescein isothiocyanate
(FITC)-conjugated anticytokine monoclonal antibodies (mAbs) to
TNF-a (anti-human TNF-a FITC) and IL-6 (anti-human IL-6
FITC), PE-conjugated anti-cytokine mAbs to IL-1b (anti-human
IL1b PE) and IL-8 (anti-human IL-8 PE), and isotype-matched
immunoglobulins (IgGs) of irrelevant specificities (FITC- or PE-
labeled mouse IgG). PC5-conjugated mAb to CD14 was purchased
from Immunotech (Tokyo, Japan). PE-labeled anti-human TLR4
mAb (HTA-125, mouse IgG2a) was obtained from Santa Cruz
Biotechnology (CA, USA). RPMI 1640 medium, phosphate-buffered
saline, paraformaldehyde, and bovine serum albumin were pur-
chased from GIBCO (Tokyo, Japan). enzyme-linked immunosor-
bent assay kits for measurement of serum TNF-a, IL-1b, IL-6, and
IL-8 levels were purchased from R&D Systems (QuantikineTM
Human Cytokine Immunoassay; Minneapolis, MN, USA).
Blood collection and measurements
Blood samples were collected from the predialysis CKD patients and
control subjects before having breakfast in the morning. Blood cell
count and routine laboratory data were obtained by using the
automated analyzer SF-3000 Sysmex (Tokyo, Japan). The serum
cytokine levels were measured by enzyme-linked immunosorbent
assay kits following the manufacturer’s protocol. We used the four-
variable (abbreviated) modification of diet in renal disease equation
to estimate the glomerular filtration rate.
Measurement of baseline expression of TLR4 on
unstimulated monocytes
One hundred micro-liter of peripheral blood was incubated with
anti-TLR4 PE mAb and anti-CD14 FITC mAb for 30 min at 41C.
The labeled blood was automatically lysed, washed, and resuspended
in 500 ml of phosphate-buffered saline (TQ-prepTM Beckman
Coulter). Samples were analyzed using a flow cytometer (Cyto-
micsTMFC500 Beckman Coulter, CA, USA) and the data were
assessed with Cytomics RXP (Beckman Coulter). The light scatter
and fluorescence channels were set at a logarithmic gain to identify
the monocyte population by cell size and granularity (gate R1). Cells
that were positive for CD14 were gated on the side-scatter versus
fluorescence 1 (SSC-FL1) plot (gate R2). The analysis below was
performed on 3000 CD 14þ monocytes within both R1 and R2
gates. The cells labeled with anti-TLR4 PE mAb and anti-CD14
FITC mAb were profiled on the FL1–FL2 plot and compared to
samples treated with anti-CD14 FITC mAb and isotype-matched
irrelevant IgG PE (negative controls). Cutoff quadrant markers were
set individually for each measurement based on the negative control.
The percentage of cells that were positive for anti-TLR4 mAb
(frequency) and their MFI were calculated on the histogram for the
assessment. All experiments were performed in duplicate and their
mean values were used for analysis. The representative figures
showing the expression of TLR4 from a control subject are
demonstrated in Figure 2.
Intracellular cytokine staining
To measure cytokine production following cell stimulation, we
employed an intracellular cytokine staining method. We used the
FASTIMMUNE Assay Systems kit (Becton Dickinson) based on the
method described by Jung et al.6 and Picker et al.6 The optimal dose
of LPS and stimulation time for cytokine synthesis had been
determined by a previously published in vitro time course study.8,18
In brief, 1 ml of peripheral blood was diluted with 1 ml of RPMI
1640 medium and then incubated with 15 mg/ml of brefeldin-A. This
disrupts the intracellular Golgi-mediated transport and allows
cytokines to accumulate within the cell thereby enhancing the
cytokine signal. Thereafter, 0.1 mg/ml of LPS was added to activate
the monocytes and the blood was then incubated for 4 h at 371C in a
CO2 incubator (5% CO2). The viability of mononuclear cells
(495%) in whole blood was evaluated using Trypan blue exclusion.
Thereafter, 500 ml of the activated blood was labeled with anti-CD14
PC5 mAb for 15 min at room temperature.
Fluorescence-activated cell sorter lysing solutions (4 ml) was
added to the activated, labeled blood and incubated for 10 min. The
sample was then washed twice with phosphate-buffered saline/0.1%
bovine serum albumin by centrifugation and the supernatant was
removed. Permeabilizing solutions (500 ml) was added and the
specimen was left for 10 min in the dark. After washing the cells
twice, cell pellets were incubated with the fluorescent anticytokine
mAbs in 50 ml of RPMI medium for 30 min in the dark. After
washing the cells by centrifugation, the supernatants were removed
and cells were fixed in 500ml of phosphate-buffered saline/1%
paraformaldehyde before being analyzed by flow cytometry. Various
intracellular cytokines including TNF-a, IL-1b, IL-6, and IL-8 were
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detected by specific mAbs. Isotype control IgGs of irrelevant
specificities were added at matching concentrations in control
samples to determine the nonspecific binding of the mAbs to the
cells.
Intracellular cytokine measurement by flow cytometry
The samples were analyzed by using a flow cytometer (Cyto-
micsTMFC500) and the data were assessed with Cytomics RXP. The
light scatter and fluorescence channels were set at a logarithmic gain
to identify monocyte population by cell size and granularity (gate
R1). Only cells that were positive for CD14 PC5 mAb were gated on
the SSC-FL3 plot (gate R2). Each analysis was performed on 5000
CD 14þ monocytes within both R1 and R2 gates. The cells labeled
with specific anticytokine mAbs were profiled on the FL1–FL2 plot
and compared to samples treated with isotype-matched irrelevant
IgGs (negative controls). Cutoff quadrant markers based on the
negative control were set individually for each measurement. The
percentage of cells that were positive for each cytokine antibody
(frequency) was calculated on the quadrant diagram for the
assessment as described previously.8 The MFI was also measured
to determine the level of cytokine synthesis. All experiments were
performed in duplicate and their mean values were used for analysis.
Statistics
The data are expressed as mean7s.d. unless otherwise stated.
Statistical analysis was performed using the Mann–Whitney U-test
to compare data between the two study groups and using the
Kruskal–Wallis test between the three study groups. Po0.05 was
considered to be statistically significant. Bivariable analyses explor-
ing the relationship of cytokine synthesis to variables were
performed using the nonparametric Spearman rank correlation test.
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Figure 2 | Flow cytometric analysis of TLR4 in peripheral
monocytes. The light scatter and fluorescence channels were set
at a logarithmic gain to identify monocyte population by cell size
and granularity. Cells that were positive for CD14 FITC mAb were
gated on the SSC-FL1 plot as described in Materials and Methods. The
cells labeled with anti-TLR4 PE mAb and anti-CD14 FITC mAb were
profiled on the FL1–FL2 plot and compared to the samples that had
been treated with anti-CD14 FITC mAb and isotype irrelevant IgG PE
((a) control IgG and (b) TLR4 mAb). Cutoff quadrant markers based on
the negative control were set individually for each measurement. The
percentage of cells that were positive for anti-TLR4 mAb (frequency)
and their MFI were calculated on the histogram for the assessment
((c) control IgG and (d) anti-TLR4 mAb).
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